Share
Entrepreneur
The COVID-19 vaccine may spell the end of the pandemic, but while mass vaccination is not available it is vital to stop community transmission. The new antiviral drug MK-4482 / EIDD-2801 or Molnupiravir, has managed to suppress “completely” the transmission of the coronavirus in just 24 hours , according to studies by the Institute of Biomedical Sciences of Georgia State University.
“This is the first demonstration of an orally available drug that quickly blocks the transmission of SARS-CoV-2 , so it could be a game changer,” the researchers explained in the work published in the journal Nature Microbiology .
The antiviral drug was developed at Emory University in Atlanta by the drug innovation company Drug Innovation Ventures at Emory (DRIVE), which was licensed by Ridgeback Biotherapeutics, which partnered with Merck & Co. Molnupiravir was originally designed to treat the flu and prevent the virus from making copies of itself, creating errors during viral RNA replication.
6 Dec 2020
RELATED TOPICS:
Trump’s Potential VP Pick Boasts About Executing Puppy
21 hours ago
Trita Parsi: Blind Support for Israel Erodes Western Democracies
21 hours ago
Fresno Trash Hauler’s Response to Overpayments: We Followed the City’s Rules
21 hours ago
Which Six QBs Were Selected in the Top 12 of the NFL Draft?
22 hours ago
Nuggets Close to Sweeping Lakers After Game 3 Win
22 hours ago
Jose Ramirez: ‘I Want to Make a Statement and Put on a Show’
22 hours ago
Yoshinobu Yamamoto’s 6 Shutout Innings Help Dodgers Finish Sweep, Defeat Nats 2-1
23 hours ago
The 49ers Add Florida Receiver Ricky Pearsall With the 30th Draft Pick
23 hours ago
Political Stunt, Egg on His Face, Personal Vendetta. Who’s Fresno DA Talking About?
24 hours ago
California Legislation Wants to Uncover the ‘Hidden Homicides’ of Domestic Violence